Linley
Linley
Search guides and tools
Download on the App Store

Educational, not medical advice.

I'm on the pill. How long do I need backup?I'm on the pill. How long do I need backup?

Pick your product, what changed and when. You see the dates the label gives and exactly what it says.Your product, what changed and when. The label's dates, word for word.

Product
What happened most recently
Your birth control

Nothing you enter here is saved or sent.

The label says to use a backup method untilUse a backup method until

Tuesday, December 1

4 weeks after your dose went up. Keep taking your pill and add condoms, or switch to a method you don't swallow. It starts again after each increase.4 weeks after your dose went up. It starts again after each increase.

Dose went up: Nov 3 Today: Nov 19, 12 days left Backup ends: Dec 1

Day 16 of 28 12 days left

What the Zepbound label says

“Advise patients using oral hormonal contraceptives to switch to a non-oral contraceptive method, or add a barrier method of contraception for 4 weeks after initiation with ZEPBOUND and for 4 weeks after each dose escalation.”
Zepbound prescribing information, sections 7.2 and 8.3, revised 08/2026. Checked November 18, 2026.
“Advise patients using oral hormonal contraceptives to switch to a non-oral contraceptive method, or add a barrier method of contraception for 4 weeks after initiation with ZEPBOUND and for 4 weeks after each dose escalation.”
Zepbound label, sections 7.2 and 8.3

This repeats the label. Ask your prescriber which method suits you.

Why the pill is affected

Tirzepatide slows how fast the stomach empties. That can lower how much of a pill your body takes in, mostly in the weeks after you start and after each increase. Methods you don't swallow aren't affected this way.Tirzepatide slows how fast the stomach empties, so less of a pill may be absorbed after you start and after each increase.

ProductWhat the label says about the pill
Zepbound, MounjaroSwitch to a non-oral method, or add a barrier method, for 4 weeks after starting and 4 weeks after each dose increase.
Wegovy, OzempicNo backup rule for the pill on the label. Ask your prescriber if you have severe vomiting or diarrhea.
Compounded tirzepatideNo FDA label. It is the same ingredient as Zepbound, so ask the prescriber whether the same rule applies.
Not on the pillPatch, ring, IUD, implant and shot are not swallowed, so the labels don't ask for backup.

Summarized from each prescribing information, sections 7.2 and 8.3. The tool shows the exact text. Checked November 18, 2026.

Zepbound, MounjaroBackup for 4 weeks after starting and after each increase.
Wegovy, OzempicNo backup rule for the pill on the label.
Compounded tirzepatideNo FDA label. Ask the prescriber whether the same rule applies.

Questions people ask

Does this mean the pill stops working?

Not necessarily. The label says Zepbound "may reduce the efficacy" of the pill, because less of its hormones may be absorbed in those weeks. No study has measured pregnancy rates, so the label asks for backup.

What if I get pregnant, or want to?

The Zepbound label says to stop when a pregnancy is recognized, because it may cause fetal harm. If you're planning a pregnancy, ask your prescriber when to stop.

I take the mini-pill. Does this apply?

The label says oral hormonal contraceptives, which includes the mini-pill. Your prescriber can confirm.

Questions people ask

Does the pill stop working?

Not necessarily. Less may be absorbed in those weeks, so the label asks for backup.

Does this apply to the mini-pill?

The label says oral hormonal contraceptives, which includes it. Your prescriber can confirm.

What if I want to get pregnant?

Ask your prescriber when to stop. The Zepbound label says to stop when a pregnancy is recognized.

Sources

1. Zepbound and Mounjaro prescribing information, sections 7.2 and 8.3, revised 08/2026. Ozempic and Wegovy prescribing information, sections 7.2, 8.3 and 12.3. Checked November 18, 2026.

Last reviewed November 18, 2026 by the Linley Team.

Sources: Zepbound and Mounjaro prescribing information, sections 7.2 and 8.3. Last reviewed November 18, 2026.